These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 6289135

  • 1. Noradrenergic neurotransmission in the brain of a convulsive mutant mouse, differences between the cerebral cortex and the brain stem.
    Maurin Y, Arbilla S, Dedek J, Lee CR, Baumann N, Langer SZ.
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Jul; 320(1):26-33. PubMed ID: 6289135
    [Abstract] [Full Text] [Related]

  • 2. Distribution of [3H]clonidine binding sites in the brain of the convulsive mutant quaking mouse: a radioautographic analysis.
    Mitrovic N, Le Saux F, Gioanni H, Gioanni Y, Besson MJ, Maurin Y.
    Brain Res; 1992 Apr 24; 578(1-2):26-32. PubMed ID: 1511279
    [Abstract] [Full Text] [Related]

  • 3. Inhibition by yohimbine of the calcium-dependent evoked release of [3H]GABA in rat and mouse brain slices in vitro.
    Maurin Y, Arbilla S, Langer SZ.
    Eur J Pharmacol; 1985 Apr 23; 111(1):37-48. PubMed ID: 2990943
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neuronal expression of mutations affecting primarily glia in the mouse: studies in the dysmyelinated and convulsive mutant quaking.
    Baumann N, Maurin Y.
    J Physiol (Paris); 1987 Apr 23; 82(4):271-8. PubMed ID: 3332690
    [Abstract] [Full Text] [Related]

  • 6. Altered postnatal ontogeny of alpha 1- and alpha 2-adrenoceptor binding sites in the brain of a convulsive mutant mouse (quaking).
    Maurin Y, Le Saux F, Graillot C, Baumann N.
    Brain Res; 1985 Oct 23; 354(2):229-35. PubMed ID: 2996717
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Further evidence for, and nature of, the facilitatory GABAergic influence on central noradrenergic transmission.
    Dennis T, Curet O, Nishikawa T, Scatton B.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov 23; 331(2-3):225-34. PubMed ID: 3003590
    [Abstract] [Full Text] [Related]

  • 9. Presynaptic alpha-adrenoceptors: do exogenous and neuronally released noradrenaline act at different sites?
    Baker DJ, Drew GM, Hilditch A.
    Br J Pharmacol; 1984 Mar 23; 81(3):457-64. PubMed ID: 6320940
    [Abstract] [Full Text] [Related]

  • 10. Release of [3H]-amezinium from cortical noradrenergic axons: a model for the study of the alpha-autoreceptor hypothesis.
    Hedler L, Starke K, Steppeler A.
    Br J Pharmacol; 1983 Apr 23; 78(4):645-53. PubMed ID: 6303483
    [Abstract] [Full Text] [Related]

  • 11. Mutual interaction between presynaptic alpha 2-adrenoceptors and opioid kappa-receptors at the noradrenergic axons of rabbit brain cortex.
    Limberger N, Späth L, Hölting T, Starke K.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 23; 334(2):166-71. PubMed ID: 3024032
    [Abstract] [Full Text] [Related]

  • 12. Regulation in the central norepinephrine neurotransmission induced in vivo by alpha adrenoceptor active drugs.
    Braestrup C, Nielsen M.
    J Pharmacol Exp Ther; 1976 Sep 23; 198(3):596-608. PubMed ID: 185355
    [Abstract] [Full Text] [Related]

  • 13. Effects of drugs affecting the noradrenergic system on convulsions in the quaking mouse.
    Chermat R, Doaré L, Lachapelle F, Simon P.
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec 23; 318(2):94-9. PubMed ID: 6276790
    [Abstract] [Full Text] [Related]

  • 14. Presynaptic alpha 2-adrenoceptors modulate the release of [3H]noradrenaline from rat spinal cord dorsal horn neurones.
    Reimann W, Schneider F.
    Eur J Pharmacol; 1989 Aug 11; 167(1):161-6. PubMed ID: 2550256
    [Abstract] [Full Text] [Related]

  • 15. Increased number of locus ceruleus noradrenergic neurons in the convulsive mutant quaking mouse.
    Maurin Y, Berger B, Le Saux F, Gay M, Baumann N.
    Neurosci Lett; 1985 Jun 24; 57(3):313-8. PubMed ID: 2863793
    [Abstract] [Full Text] [Related]

  • 16. alpha-Adrenoceptor-mediated inhibition of noradrenaline release in rabbit brain cortex slices. Receptor properties and role of the biophase concentration of noradrenaline.
    Reichenbacher D, Reimann W, Starke K.
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Apr 24; 319(1):71-7. PubMed ID: 6125897
    [Abstract] [Full Text] [Related]

  • 17. Uptake, release, and modulation of release of noradrenaline in rabbit superior colliculus.
    Wichmann T, Starke K.
    Neuroscience; 1988 Aug 24; 26(2):621-34. PubMed ID: 2845297
    [Abstract] [Full Text] [Related]

  • 18. Presynaptic alpha 2-adrenoceptor, opioid kappa-receptor and adenosine A1-receptor interactions on noradrenaline release in rabbit brain cortex.
    Limberger N, Späth L, Starke K.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul 24; 338(1):53-61. PubMed ID: 2907100
    [Abstract] [Full Text] [Related]

  • 19. Role of adenylate cyclase in presynaptic alpha 2-adrenoceptor- and mu-opioid receptor-mediated inhibition of [3H]noradrenaline release from rat brain cortex slices.
    Schoffelmeer AN, Wierenga EA, Mulder AH.
    J Neurochem; 1986 Jun 24; 46(6):1711-7. PubMed ID: 2422322
    [Abstract] [Full Text] [Related]

  • 20. Long-term treatment with clonidine and alpha-receptors in the brain of normotensive rats.
    Cerrito F, Martire M, Preziosi P.
    Brain Res; 1984 Oct 29; 321(1):45-54. PubMed ID: 6093931
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.